Instil Bio (TIL) Retained Earnings (2020 - 2026)

Instil Bio has reported Retained Earnings for 7 years, with the latest figure at $843.0 million in Q2 2026.

• On a quarterly basis, Retained Earnings rose 0.69% year-over-year to $843.0 million in Q2 2026; TTM through Jun 2026 was $843.0 million, a 0.69% increase from a year earlier, with the FY2025 full-year figure at $840.9 million, up 1.96% from the prior year.
• Retained Earnings was $843.0 million for Q2 2026 at Instil Bio, roughly flat from $841.9 million in the prior quarter.
• The five-year high for Retained Earnings was $843.0 million in Q2 2026, with the low at $764.8 million in Q1 2022.
• Average Retained Earnings over 5 years is $811.9 million, with a median of $813.8 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Retained Earnings climbed 4.69% in 2022, then grew 0.69% in 2026.
• Over 5 years, Retained Earnings stood at $789.0 million in 2022, then advanced by 2.3% to $807.2 million in 2023, then gained by 2.18% to $824.8 million in 2024, then rose by 1.96% to $840.9 million in 2025, then rose by 0.24% to $843.0 million in 2026.
• The last three Retained Earnings figures came in at $843.0 million (Q2 2026), $841.9 million (Q1 2026), and $840.9 million (Q4 2025), per Business Quant data.